Flora Growth Corp. (“Flora” or the “Company”) is pleased to announce that its Flora Beauty division has signed an agreement with the largest Latin American retailer Grupo SACI Falabella (BCS:FALABELLA) (“Falabella”) to distribute Paulina Vega’s CBD skincare brand Minds Naturals. The first official order has already been received from Falabella in Colombia and is in process of being fulfilled.
- Falabella, the Macy’s of Latin America, is one of the largest retailers in Latin America, with over 250 retail locations, serving more than 30 million customers and generating over $8 billion in revenues in 2019.
- Mind Naturals products will be available for purchase in up to 111 Falabella retail locations across Latin America.
- Initial rollout will start with the 15 highest-traffic retail centres in Colombia, with products already available.
- Mind Naturals products will also be available through online channels across Falabella’s e-retailer Linio, which sees over 290 million visitors per year and on Fallabella.com.
“The addition of Mind Naturals products to Falabella’s portfolio represents a massive step in the growth of Flora Beauty’s inaugural brand,” commented Flora Growth’s President of Consumer Goods. “Our products are developed by and intended for Latin American consumers. By having Mind Naturals products available through one of the largest retailer like Falabella, we can ensure we reach a maximum number of target consumers and more importantly, that those consumers can access the high-quality and sustainable beauty and skincare products they desire.”
About the Distribution Agreement
Through this distribution agreement, Falabella will sell the full portfolio of Flora Beauty’s inaugural CBD skincare line Mind Naturals. The products will be sold initially in 15 physical retail locations in Colombia, with a focus on the highest-traffic retail centres. Falabella will be Flora Beauty’s exclusive retail partner in Colombia.
Mind Natural will also be available through Falabella’s growing e-commerce channels, Linio and Falabella.com, which operate across Brazil, Peru, Chile, Colombia, Argentina, among others. This agreement creates the potential for Flora Beauty to expand distribution across other Latin American jurisdictions.
About Flora Beauty
Flora Beauty is Flora Growth’s beauty and cosmetics division that produces natural beauty and skincare products with CBD to help consumers restore and thrive. The division currently has two lifestyle brands that will be produced using Flora’s CBD-oil.
Flora Beauty’s Mind Naturals brand will cater to younger consumers that are starting a skincare regimen. In contrast, Flora Beauty’s AWE brand will cater to the prestige market and is intended for consumers who value customized and personal experiences. Both brands incorporate the present-day expectations of consumers by focusing on high quality products with natural ingredients and prioritizing social responsibility and the environment.
Earlier this Summer, Flora Beauty announced the launch of its Mind Naturals brand, initially selling its products via electronic channels (https://mindskincare.com/) and targeting customers in Colombia and the United States. Flora Beauty’s Awe brand is expected to launch ecommerce sales later in 2020, while the launch of brick and mortar retail stores is expected by the Fall of 2021.
Flora Growth Corp.
Flora is a vertically integrated cannabis company striving to be a globally recognized cannabis brand by leveraging low-cost production of cannabis to supply CBD oil to our portfolio of consumer and medical brands. Flora prioritizes organic ingredients and value-chain sustainability across its portfolio to create products that help consumers restore and thrive.
For further information, contact:
+1 416 571 9037
This news release may contain forward-looking statements. These statements include statements regarding the Company’s operations, including the partnership with Paulina Vega, the development of Flora’s consumer facing divisions, the Company’s strategy, and future plans and objectives. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially. We do not assume any obligation to update any forward-looking statements, except as required by applicable laws.
CAUTIONARY STATEMENT CONCERNING FORWARD LOOKING STATEMENTS
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this document and other statements made from time to time by us or our representatives might not occur.